|
| Status |
Public on Jun 12, 2024 |
| Title |
TFG-MET_Allograft_2 |
| Sample type |
genomic |
| |
|
| Source name |
TFG-MET_Allograft_brain_tumor
|
| Organism |
Mus musculus |
| Characteristics |
strain: CD1
|
| Treatment protocol |
NA
|
| Growth protocol |
NA
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
Illumina protocol
|
| Label |
bioton/DNP
|
| Label protocol |
Illumina protocol
|
| |
|
| Hybridization protocol |
Illumina protocol
|
| Scan protocol |
Illumina HiScan System according to the manufacturer's protocol
|
| Description |
Methylation data from murine allograft tumors with human TFG-MET fusion gene.
|
| Data processing |
Raw IDAT files from the mouse model MM285k arrays were pre-processed with the sesame package (v1.14.2) with the default "TQCDPB" preprocessing steps. Noob normalization was applied to all samples to derive beta values.
Noob normalized beta values
|
| |
|
| Submission date |
Jan 03, 2024 |
| Last update date |
Jun 12, 2024 |
| Contact name |
Jared Andrews |
| E-mail(s) |
jared.andrews@stjude.org
|
| Organization name |
St. Jude Children's Research Hospital
|
| Department |
Developmental Neurobiology
|
| Street address |
262 Danny Thomas Pl
|
| City |
Memphis |
| State/province |
Tennessee |
| ZIP/Postal code |
38105 |
| Country |
USA |
| |
|
| Platform ID |
GPL32685 |
| Series (2) |
| GSE252459 |
Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy. |
| GSE252500 |
Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy (mouse methylation array) |
|
